Ex vivo expansion of stem cells: Defining optimum conditions using various cytokines

Laboratory Hematology

Volumn 12, Issue 2, 2006, Pages 86-93

  Mohamed, Azza A ^a   Ibrahim, Azza M ^a   El Masry, Manal W ^a   Mansour, Iman Maher ^a,b   Khroshied, Mervat A ^a   Gouda, Heba M ^a   Riad, Raafat M ^a  

^a CAIRO UNIVERSITY   (Egypt)

^b NONE   (Egypt)

Author keywords

Cord blood; Ex vivo expansion; Stem cells

Indexed keywords

CYTOKINE; FLT3 LIGAND; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HEMOPOIETIC GROWTH FACTOR; INTERLEUKIN 3; INTERLEUKIN 6; STEM CELL FACTOR; THROMBOPOIETIN;

APOPTOSIS; ARTICLE; CD34 SELECTION; CELL COUNT; CELL CULTURE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; CULTURE MEDIUM; EX VIVO STUDY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; PLACENTA; STATISTICAL ANALYSIS; STEM CELL; UMBILICAL CORD;

ANTIGENS, CD34; ANTIGENS, CD95; CELL CULTURE TECHNIQUES; CELL PROLIFERATION; CYTOKINES; FETAL BLOOD; HEMATOPOIETIC CELL GROWTH FACTORS; HEMATOPOIETIC STEM CELLS; HUMANS; TIME FACTORS;

EID: 33745883753     PISSN: 10802924     EISSN: None     Source Type: Journal    
DOI: 10.1532/LH96.05033     Document Type: Article

References (32)

1. Traycoff C, Abboud M, Laver J, et al. Evaluation of in vitro behavior of phenotypically defined population of umbilical cord blood haematopoietic progenitor cells. Exp Hematol. 1994;22:215-222.
2. Maggakis-Kelemen C, Bork M, Kayser P, Biselli M, Artmann GM. Biological and mechanical quality of red blood cells cultured from human umbilical cord blood stem cells. Med Biol Eng Comput. 2003;41:350-356.
3. Gluckman E, Rocha V, Boyer-Chammard A. Outcome of cord blood transplantation from related and unrelated donors. N Eng J Med. 1997;337:373-381.
4. Wang SY, Hsu ML, Huang MZ, et al. The activity in ex vivo expansion of cord blood myeloid progenitor cells before and after cryopreservation. Acta Hematol. 2001;105:38-44.
5. Lewis ID. Clinical and experimental uses of umbilical cord blood. Intern Med J 2002;32:601-609.
6. McNiece IK, Bertoncello I, Kriegler AB, et al. Colony-forming cells with high proliferative potential (HPP-CFC) [review]. Int J Cell Cloning. 1990;8:146.
7. Piacibello W, Sanavio F, Garetto L, et al. Extensive amplification and self-renewal of human primitive hematopoietic stem cells from cord blood. Blood. 1997;89:2644-2653.
8. Breems DA, Blokand EAW, Siebel KE, et al. Stroma-contact prevents the loss of hematopoietic stem cell quality during ex vivo expansion of CD34-positive mobilized peripheral blood stem cells. Blood. 1998;91:111-117.
9. Campany G, Querol S, Antonio J, Garcia J. Short-term, serum-free, static culture of cord blood-derived CD 34+ cells: effects of Flt-3 and MIP-α on in vitro expansion of haematopoietic progenitor cells. Haematologica. 1999;84:675-682.
10. Köhler T, Plettig R, Wetzstein W, et al. Defining optimum conditions for the ex vivo expansion of human umbilical cord blood cells. Influences of progenitor enrichment, interference with feeder layer, early-acting cytokines and agitation of culture vessels. Stem Cells. 1999;17:19-24.
11. Marone M, De Ritis D, Bonanno G, et al. Cell cycle regulation in human haematopoietic stem cells: from isolation to activation. Leuk Lymphoma. 2002;43:493-501.
12. Mayani H, Guilbert LJ, Janowska-Wieczorek A. Biology of the haematopoietic microenvironment [review]. Eur J Haematol. 1992;49:225-233.
13. Douay L. Experimental culture conditions are critical for ex vivo expansion of haematopoietic cells. J Hematother. 2001;10:341-346.
14. Gotze KS, Ramirez M, Tabor K, et al. Flt3 high and Flt3 low CD34+ progenitor cells isolated from human bone marrow are functionally distinct. Blood. 1998;91:1947-1958.
15. Ohmizono Y, Sakabe H, Kimura T, et al. Thrombopoietin augments ex vivo expansion of human cord blood-derived haematopoietic progenitors in combination with SCF and Flt-3. Leukemia. 1997;11:524-530.
16. Qiu L, Meagher R, Welhausen S, Heye M, Brown R, Herzing RH. Ex vivo expansion of CD 34+ umbilical cord blood cells in serum free medium (QBSF-60) with early effect of cytokines. J Hematother Stem Cell Res. 1999;8:609-618.
17. Nitsche A, Junghahn I, Thulke S, et al. Interleukin-3 promotes proliferation and differentiation of human haematopoietic stem cells but reduces their repopulation potential in NOD/SCID mice. Stem Cells. 2003;21:236-244.
18. Poloni A, Giarratana MC, Firat H, Kobari L, Gorin NC, Douay L. The ex vivo expansion capacity of normal human bone marrow is dependent on experimental conditions: role of the cell concentration, serum, and CD 34+ cell selection in stroma free cultures. Hematol Cell Ther. 1997;39:49-58.
19. Fietz T, Berdel WE, Rieder H, et al. Culturing human umbilical cord blood: a comparison of mononuclear vs CD34+ selected cells. Bone Marrow Transplant. 1999;23:1109-1115.
20. Balducci E, Azzarello G, Valenti MT, et al. The impact of progenitor enrichment, serum and cytokines on the ex vivo expansion of mobilized peripheral blood stem cells: a controlled trial. Stem Cell. 2003;21:33-40.
21. Schibler KR, Li Y, Ohls RK, et al. Possible mechanisms accounting for the growth factor independence of hematopoietic progenitors from umbilical cord blood. Blood. 1994;84:3679-3684.
22. Tang S, Li Y, Wang M, Yang C. Research on expression of CD 34+ cells from umbilical cord blood using different cytokine groups in vitro. Sichuan Da Xue Xue Bao Yi Xue Ban. 2003; 34:398-400.
23. Encabo A, Mateu E, Carbonell-Uberos F, Minana MD. Interleukin-6 precludes the differentiation induced by interleukin-3 on expansion of CD 34+ cells from cord blood. Hematologica. 2003;88:388-395.
24. Mantel C, Hendrie P, Broxmeyer HE. Steel factor regulates cell cycle asymmetry. Stem Cells. 2001;19:483-491.
25. Smith MA, Court EL, Smith JG. Stem cell factor: laboratory and clinical aspects. Blood Rev. 2001;15:191-197.
26. Sui X, Tsuji K, Tanaka R, et al. Gp130 and c-kit signalings synergize for ex vivo expansion of human primitive hematopoietic progenitor cells. Proc Natl Acad Sci USA. 1995;92:2859-2863.
27. Feng JF, Zhuang M, Zhu LJ, Sheng ZL, Zhu YQ, Li CP. Effect of IL-6/ sIL-6R on ex vivo expansion of human cord blood derived CD34+ cells. Ai Zheng. 2004;23:715-718.
28. Matsumoto K, Yasui K, Yamashita N, et al. In vitro proliferation potential of AC 133 positive cells in peripheral blood. Stem Cells. 2000;18:196-203.
29. Möbest D, Goan SR, Junghahn I, et al. Differential kinetics of primitive haematopoietic cells assayed in vitro and in vivo during serum free suspension culture of CD 34+ blood progenitor cells. Stem Cell. 1999;17:152-161.
30. Firat H, Douay L. Ex-vivo expansion of mobilized peripheral blood stem cells. Stem Cells. 1997;10:98.
31. Donaldson C, Denning-Kendall P, Braddley B, Hows J. The CD34+ CD38- population is significantly increased in haematopoietic cell expansion cultures in serum free compared to serum replete conditions: dissociation of phenotype and function. Bone Marrow Transplant. 2001;27:365-371.
32. Berger M, Fagioli F, Piacibello W, et al. Role of different medium and growth factors on placental blood stem cell expansion: an in vitro and in vivo study. Bone Marrow Transplant. 2003;29:443-448.